Patents Examined by Nam P Nguyen
  • Patent number: 11459406
    Abstract: The present disclosure generally relates to nanoparticles adsorbed with gliadin molecules. In addition, the present disclosure relates to methods of preparing the nanoparticles adsorbed with gliadin molecules and methods of using said nanoparticles including detecting anti-gliadin 5 antibodies in a sample, diagnosing gluten-related disorders, and other applications.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: October 4, 2022
    Assignee: UNIVERSITY OF TECHNOLOGY SYDNEY
    Inventors: Michael Wallach, Olga Shimoni, Buket Demirci, Anantdeep Kaur
  • Patent number: 11442062
    Abstract: A compound is provided which is effectively adsorbed to a substrate surface, such as an immune reaction vessel, has extremely high protein adsorption inhibitory effect that inhibits non-specific adsorption of protein or the like, and has excellent washability to retain the inhibitory effect before and after washing operation of the substrate. Also provided are a protein adsorption inhibitor using the compound, a phosphorylcholine-modified substrate, and a method for inhibiting protein adsorption. The compound is a phosphorylcholine group-containing polyethylene glycol derivative represented by formula (1). The method for inhibiting protein adsorption of the present invention includes the step of forming an adsorbed layer of the derivative on a substrate surface.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: September 13, 2022
    Assignee: NOF Corporation
    Inventors: Akane Katori, Masaru Matsuda, Tomozumi Noda, Takashi Sasaki, Hirotaka Suzuki, Nobuyuki Sakamoto
  • Patent number: 11442070
    Abstract: An object of the present invention is to provide a blood analysis method and a blood test kit, which are capable of performing measurement of a plurality of target components to be analyzed with high accuracies in a case where hemolysis occurs in a case of measuring an amount of target components to be analyzed in a small volume of a blood sample.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: September 13, 2022
    Assignee: FUJIFILM Corporation
    Inventors: Kota Fukui, Shinya Sugimoto, Isao Yonekubo
  • Patent number: 11435348
    Abstract: It is an object of the present invention to provide a tissue staining method that makes it possible to observe both information on the morphology of a tissue and information on a biological substance such as an antigen molecule to be detected on a single section and in a single view field. The present invention provides a tissue staining method, including carrying out (A) a HE (hematoxylin-eosin) staining, and (B) a histochemical staining, serially on a single tissue section, wherein the histochemical staining is defined as a histochemical technique for detecting a biological substance to be detected in a tissue in a visible manner by use of a binding reaction between the biological substance to be detected and a probe biological substance capable of binding specifically to the biological substance to be detected.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: September 6, 2022
    Assignee: KONICA MINOLTA, INC.
    Inventors: Hideki Gouda, Hisatake Okada, Yasushi Nakano, Kohsuke Gonda, Noriaki Ohuchi, Mika Watanabe
  • Patent number: 11428695
    Abstract: Methods for producing high concentration protein formulations having high stability are provided. Assays for selecting proteins and formulation conditions that have high self-repulsive attributes are used as an early step in the manufacturing process. Specifically, a protein concentration-dependent self-interaction nanoparticle spectroscopy method is employed as a protein colloidal interaction assay.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: August 30, 2022
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Michael Marlow, Michael Sennett, Michael Schneider
  • Patent number: 11415571
    Abstract: Methods, systems, and software are provided for using organoid cultures, e.g., patient-derived tumor organoid cultures, to improve treatment predictions and outcomes.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: August 16, 2022
    Assignee: Tempus Labs, Inc.
    Inventors: Brian M. Larsen, Michelle M. Stein, Luka A. Karginov, Ameen Salahudeen, Madhavi Kannan, Aly A. Khan, Verónica Sánchez Freire, Yilin Zhang
  • Patent number: 11415576
    Abstract: The present invention concerns an in vitro method for measurement of 25-hydroxyvitamin D, wherein the potentially interfering compound 24,25-dihydroxyvitamin D3 is blocked by a binding agent specifically binding to 24,25-dihydroxyvitamin D3 and not binding to 25-hydroxyvitamin D.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: August 16, 2022
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Elke Faatz, Michael Gerg, Hans-Peter Josel, Christian Vogl
  • Patent number: 11408884
    Abstract: Lyophilized chromophoric polymer dot compositions are provided. Also disclosed are methods of making and using the lyophilized compositions, methods of dispersing the lyophilized compositions in aqueous solutions and kits supplying the compositions.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: August 9, 2022
    Assignee: University of Washington through its Center for Commercialization
    Inventors: Daniel T. Chiu, Wei Sun, Jiangbo Yu, Changfeng Wu, Fangmao Ye
  • Patent number: 11391733
    Abstract: Disclosed is a method for measurement of an analyte in a microparticle-based analyte-specific binding assay, wherein the microparticles are coated with the first partner of a binding pair, the method involving mixing the coated microparticles, an analyte-specific binding agent conjugated to the second partner of the binding pair, and a sample suspected of containing or containing the analyte, wherein the second partner of the binding pair is bound to the analyte-specific binding agent via a linker having from 12 to 30 ethylene glycol units (PEG 12 to 30), thereby binding the analyte via the conjugated analyte-specific binding agent to the coated microparticles, separating the microparticles having the analyte bound via the binding pair and the analyte-specific binding agent from the mixture and measuring the analyte bound to the microparticles.
    Type: Grant
    Filed: February 19, 2018
    Date of Patent: July 19, 2022
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Toralf Zarnt, Dieter Heindl, Alfons Nichtl, Frank Sicherl-Birk
  • Patent number: 11391728
    Abstract: The present invention may provide phosphor-integrated nanoparticles whose precipitation and/or aggregation, particularly aggregation can be inhibited upon carrying out immunostaining therewith and which can thus be used for staining even after long-term storage without requiring a complicated operation, the phosphor-integrated nanoparticles preferrably maintaining excellent performance, such as staining properties, even after long-term storage. The phosphor-integrated nanoparticles of the present invention have an average sphericity (f) of 0.80 to 0.95 and preferably have an average circumference ratio (R) of 0.50 to 0.95.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: July 19, 2022
    Assignee: KONICA MINOLTA, INC.
    Inventors: Takeshi Isoda, Masaru Takahashi
  • Patent number: 11391736
    Abstract: Disclosed is an analyte detection method, including detecting an analyte in such a state that a complex composed of the analyte in a sample of interest, a particle capable of bonding to the analyte and a trapping substance capable of bonding to the analyte is formed on a substrate, wherein the analyte is detected on the basis of an index associated with a behavior of the particle.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: July 19, 2022
    Assignee: SYSMEX CORPORATION
    Inventors: Kenji Akama, Hiroyuki Noji
  • Patent number: 11382986
    Abstract: A method for exchange imaging of at least two targets in a sample includes (a) incubating a sample with at least two or more target-recognizing antibodies, each bound to a corresponding monovalent tight antibody binder-docketing moiety (MTAB-DM) reagent capable of binding monovalently to the target-recognizing antibodies, (b) applying at least two imager moieties corresponding to the MTAB-DM, either in series, in batches, or in parallel, and (d) imaging the at least two imager moieties either in series, in batches, or in parallel.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: July 12, 2022
    Assignee: ULTIVUE, INC.
    Inventor: Xi Chen
  • Patent number: 11385225
    Abstract: The present invention relates to tri-functional crosslinking reagents carrying (i) a ligand-reactive group for conjugation to a ligand of interest having at least one binding site on a target glycoprotein receptor, (ii) a hydrazone group for the capturing of oxidized receptor-glycoproteins and (iii) an affinity group selected from azides and alkynes for the detection, isolation and purification of captured glycoproteins; as well as their manufacturing. The invention further provides for improved methods of detecting, identifying and characterizing interactions between ligands and their corresponding target glycoproteins on living cells and in biological fluids. The invention further provides for new uses of catalysts in such methods.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: July 12, 2022
    Assignee: ETH Zurich
    Inventors: Erick Moran Carreira, Michael Andreas Schafroth, Nadine Sobotzki, Bernd Wollscheid
  • Patent number: 11378517
    Abstract: A biological substance detection method for detecting a biological substance specifically in a pathological specimen, includes a step of immunologically staining the pathological specimen using a fluorescent label, a step of staining the pathological specimen with a staining reagent for morphology observation purposes (eosin) to observe the morphology of the pathological specimen, a step of irradiating the stained pathological specimen with excited light to cause the emission of a fluorescent and detecting the biological substance in the pathological specimen. In the step of immunologically staining the pathological specimen, a special fluorescent particle for which the excitation wavelength appears in a region that is different from the excitation wavelength region of eosin is used as the fluorescent label.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: July 5, 2022
    Assignee: KONICA MINOLTA, INC.
    Inventors: Kensaku Takanashi, Hideki Goda, Hisatake Okada, Yasushi Nakano, Kohsuke Gonda, Motohiro Takeda, Noriaki Ohuchi
  • Patent number: 11371994
    Abstract: The present application provides stable peptide-based Akt capture agents and methods of use as detection and diagnosis agents and in the treatment of diseases and disorders. The application further provides methods of manufacturing Akt capture agents using iterative on-bead in situ click chemistry.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: June 28, 2022
    Assignee: CALIFORNIA INSTITUTE OF TECHNOLOGY
    Inventors: James R. Heath, Arundhati Nag, Samir Das, Joseph O. Varghese, Ryan K. Henning
  • Patent number: 11366090
    Abstract: A method for the inactivation and inactivation testing of xenoantigens in foods of vegetable and animal origin, comprising the following steps: making up a solution with a food of vegetable or animal origin as a solvent and one or more phenolic compounds, polyphenolic compounds and derivatives thereof, comprising phenylpropanoids, as a solute, for the inactivation of at least part of the xenogeneic epitopes from said food, incubating samples of the food of vegetable or animal origin with the addition of an antibody aimed at a xenoantigen epitope that is present in the food, separating the resulting immune complex created owing to the bond between antigen and antibody, preparing a well plate for the E.L.I.S.A.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: June 21, 2022
    Assignee: Biocompatibility Innovation S.R.L.
    Inventors: Filippo Naso, Alessandro Gandaglia, Ugo Stefanelli
  • Patent number: 11339419
    Abstract: Composition(s), device(s), kit(s), and method(s) for an improved analyte detection sensor(s) comprising at least one scavenger protein and method(s) of preserving the functioning and functional life of the improved analyte detection sensor(s).
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: May 24, 2022
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Janine Cox, Christopher Lawrence, Murli Narayan, David Ledden
  • Patent number: 11340231
    Abstract: Methods of identifying a compound, such as a test compound, and applications thereof are provided. For example, methods of identifying a compound that preferentially affects, increases, or decreases a level of association of a macromolecule with one or more target condensates or methods of identifying a compound that preferentially causes a macromolecule to associate or disassociate with one or more target condensates are provided. Additionally, methods of designing and/or identifying and/or making a compound, or portion thereof, with a desired characteristic are provided.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: May 24, 2022
    Assignee: DEWPOINT THERAPEUTICS, INC.
    Inventors: Alexander Szewczak, Ina Poser, Mark Andrew Murcko, Stephen Paul Hale, Bruce Aaron Beutel
  • Patent number: 11320356
    Abstract: Providing a method of estimating the number of microparticles such as microorganisms in a sample, without performing complicated operations. The method comprises counting by constant flow the number of target microorganisms contained in the sample at a predetermined flow rate, sectioning measurement data obtained as a result of the constant flow counting into a predetermined number of sections by a predetermined unit time for a section, counting the number of sections in which microorganisms are detected and the number of sections in which they are not detected, in the predetermined number of sections; and estimating the number of microorganisms in the sample, by a statistical method from the flow rate of the sample in the constant flow counting step, the predetermined number of sections and the predetermined unit time in the sectioning step, and the number of sections in which microorganisms are detected in the counting step.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: May 3, 2022
    Assignees: METAWATER CO., LTD.
    Inventors: Takuro Endo, Kyungju Kim, Dabide Yamaguchi
  • Patent number: 11320425
    Abstract: Disclosed is a diagnostic kit for quickly diagnosing a target material with high sensitivity using nanoparticles that absorb infrared light and emit infrared light, in which the nanoparticles are maintained in particle size and have enhanced emission intensity.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: May 3, 2022
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Joon Seok Lee, Seok Lee, Man Ho Choi, Hee Soo Pyo, Seung Ki Kim, Jae Young Kim